As the olfactory system is closely connected with the brain areas responsible for the most crucial alterations in psychiatric populations, especially cognitive and emotional impairments, the study of olfactory processing may be a relevant approach to identify specific markers of alcohol dependence. The aim of this study was to propose the probable olfactory markers for alcohol dependence through a study of the olfactory parameters that involve the central olfactory pathway. We recruited the same 41 alcohol-dependent patients in an early (day 8) and late (day 67) stage of abstinence and 41 controls matched for gender, age, and smoking status. The participants underwent clinical assessments and several olfactory evaluations. The results revealed on one hand, the persistence of decreased intensity of positive emotion (happy), increased intensity of negative emotion (sad), and increased citation of surprise in patients, suggesting the presence of probable trait markers of alcohol dependence. On the other hand, we found decreased hedonic score for pleasant and neutral odorants, and decreased odor familiarity judgment only in the early stage of evaluation as probable state markers for alcohol dependence. These results may be underpinned by several neuropsychological alterations specific to this disease and their evolution after weaning. Further studies are needed to replicate these findings and to confirm the specificity and sensitivity of the olfactory tests in a larger sample of patients. The olfactory perception of all controls must be also retested in order to determine the specific state and/or trait markers of alcohol dependence.
Introduction
During the last decade, numerous studies have suggested that olfactory deficits may constitute a marker or an early diagnostic tool for some neurodegenerative (e.g. Alzheimer's disease, Parkinson's disease) and psychiatric (e.g. depression, schizophrenia) disorders (Djordjevic et al. 2008; Naudin et al. 2012) . Regarding psychiatric disorders, it has also been suggested that the impairment of some olfactory parameters is associated with a major depressive episode (state marker), whereas other impairments persist after the clinical improvement of depressive symptoms (trait marker) (Naudin et al. 2012) . These findings have enriched the theoretical and clinical understanding of these conditions by proposing that each disorder may be characterized by a specific impairment pattern of olfactory abilities (Atanasova et al. 2008) . Thus, olfactory processing constitutes a topic of increasing importance in psychiatry because the olfactory system is closely connected with the brain areas responsible for the most crucial alterations in psychiatric populations, especially cognitive and emotional impairments. However, these assumptions have only been explored in schizophrenia and depression (Turetsky et al. 2009; Naudin et al. 2012) . The lack of data is particularly apparent with regard to alcohol dependence despite evidence that it is the most widespread psychiatric disorder, and olfaction may be involved in its development and maintenance (Maurage et al. 2014) .
The few studies that have explored olfaction in alcohol-dependent patients (without Korsakoff's syndrome) have been contradictory. Some authors have demonstrated a deficit in odor threshold, odor identification, discrimination, and odor judgment (odor familiarity and edibility) (Potter and Butters 1979; Ditraglia et al. 1991; Rupp et al. 2003; Rupp et al. 2004) , whereas other authors have observed a preserved odor threshold (Maurage et al. 2011 ) and odor identification (Kesslak et al. 1991) . These discrepancies may be explained by differences in the methodology used and differences in patients' comorbidities. Moreover, to our knowledge, only 1 study has explored 1 olfactory parameter (odor identification) at different stages of alcohol abstinence: an early stage and after several months of abstinence (Ditraglia et al. 1991) . This research does not allow us to determine olfactory functions that could be considered state (disappearance of olfactory alterations after abstinence) or trait (persistent olfactory alterations after abstinence) markers of alcohol dependence. This issue is crucial for understanding the effects of abstinence and the status of patients during this period. Consequently, in this study, we investigated several olfactory parameters in the first stage of alcohol abstinence and 9 weeks later to propose the probable olfactory markers of alcohol dependence.
One study that investigated odor pleasantness found no difference between alcohol-dependent patients and controls (Rupp et al. 2004 ). This observation is not consistent with the expected results given the substantial alteration of emotions associated with alcohol dependence (Maurage et al. 2012) . One potential explanation for this finding is that the authors calculated the subjects' pleasantness scores by including all odors irrespective of their hedonic valence. This method does not emphasize the differences between odorants, which is of particular importance in alcohol dependence because a number of clinical studies have provided clear evidence of the presence of anhedonia (inability to experience pleasure) in alcohol-dependent subjects (Heinz et al. 1994) . Furthermore, the hedonic valence of a component can influence the subject's ability to evaluate different olfactory functions, such as odor identification, intensity discrimination, intensity, and familiarity perception.
Moreover, it has been demonstrated that anhedonia can be detected in some psychiatric disorders through the use of odorants or flavors with different hedonic valence and through the investigation of several olfactory parameters (Eiber et al. 2002; Atanasova et al. 2010; Clepce et al. 2010; Naudin et al. 2014) . For these reasons, it is crucial to study olfactory functions using different odorants to evaluate their specific emotional impact on olfactory capabilities. Consequently, in this study, we used olfactory stimuli with different hedonic valences (3 groups of odorants: pleasant, unpleasant, and neutral) and calculated the scores separately for each group. Chronic alcoholism is often characterized by alexithymia (difficulty in recognizing, processing, and regulating the emotional response to a given stimulus) (for review, see Thorberg et al. 2009 ). To our knowledge, odor features, such as the emotion induced by an odor and its perceived intensity, which may reflect the presence of alexithymia at the olfactory level, have not yet been studied. In this pilot study, we investigate for the first time this aspect of olfactory processing in alcohol dependence.
The main aim of this research was to propose the probable olfactory markers for alcohol dependence via an examination of several olfactory parameters during the early stage of abstinence (at day 8) and after 9 weeks of treatment and controlled alcohol abstinence (at day 67). The studied olfactory parameters included the odor hedonic valence and familiarity, the emotional impact of odor and its intensity level and the evaluation, and discrimination of odor intensities.
We hypothesized that patients at D8 and/or patients at D67, compared with controls, would have deficits in several olfactory parameters according to the hedonic valence of the stimuli. Regarding emotion induced by odor, we assumed that patients would choose the positive emotion less frequently than the controls and that they would evaluate it as less intense. Regarding the odor's hedonic feature, we hypothesized that patients would evaluate pleasant odorants as less pleasant. The odors' familiarity and intensity level and the odors' intensity discrimination were also investigated. Furthermore, we studied the relationship between the clinical state of the subjects and their olfactory perception.
Materials and methods

Participants
Forty-one inpatients with alcohol dependence based on the DSM-IV criteria (American Psychiatric Association 1994) were consecutively recruited following admission to the alcohol rehab centre "Louis Sevestre" (La Membrolle-sur-Choisille, France) for addiction treatment. The French version of the Mini International Neuropsychiatric Interview (MINI 5.0.0; Sheehan et al. 1998 ) was used by a trained psychiatrist to determine the psychiatric comorbidities in each patient. All 41 alcohol-dependent patients were retested after a controlled abstinence of approximately 2 months. Thus, 2 evaluations were performed. The first evaluation was conducted at the beginning of the hospitalization after 9.9 ± 3.8 days of controlled abstinence (patients at D8 or D8), and the second evaluation was conducted after 66.6 ± 6.5 days of controlled abstinence (patients at D67 or D67). At the first evaluation, the subjects' last alcohol consumption was within 15 days (9.9 ± 3.8 days since last drink; minimum number of days of abstinence: 3 days; maximum number of days of abstinence: 15 days). The average alcohol intake of patients was 2.6 ± 2.1 l/day (considering all alcoholic drinks: wine, beer, and spirituous). The average duration of the alcohol consummation was 7.8 ± 6.8 years. In order to avoid the occurrence of adverse effects of withdrawal syndrome, the majority of the patients had an alcohol withdrawal preventive therapy: diazepam (85.4%; 25.2 ± 21.2 mg/ day) and vitamins B1 and B6. The patients were treated also with one or several alcohol dependence drugs among which acamprosate, naltrexone, disulfiram, and/or combined treatment. At the second evaluation, the subjects had not engaged in recent alcohol consumption, and they had the same alcohol-dependence treatment as the first evaluation. Moreover, only 26.8% of patients were still treated with benzodiazepines.
In addition, several patients (patients at D8 and D67) were treated for different chronic pathologies; 2 patients had treatment for hypothyroidism, 2 had treatment for cholesterol, 4 had antihypertensive therapy, and another had an antihistamine treatment. Besides, 5 patients were treated with antidepressant treatment. This treatment was prescribed to treat anxiety but none of the patients had a diagnosis of major depression episode.
A control sample of 41 healthy volunteers matched with the patients according to gender (χ 2 = 0, P = 1), smoking status (χ 2 = 0.1, P = 0.7), and age (U = 1011, P = 0.11), and with no history of mental illness or drug dependence was also included in the study. In order to test the reliability of the results, 6 persons were retested after 64.7 ± 5.3 days (controls at D65). Their demographic and clinical characteristic, their results of the psychometric scales and the olfactory tests are presented in a Supplementary material. The Montgomery-Åsberg Depression Rating Scale, MADRS (Montgomery and Asberg 1979) , was used to assess the severity of depressive symptoms in the healthy controls and patients at inclusion and after 67 days of abstinence. The MADRS scores of both patient groups were significantly higher compared to controls, but very weak to observe a major depression (Table 1) .
Subjects were excluded from the study for the following reasons: (i) a history of neurological disorders or traumatic brain injury; (ii) major medical problems; (iii) allergy to some odors and/or foods; and (iv) other conditions known to affect cerebral and/or olfactory functioning (i.e., upper respiratory tract infection). All subjects were selected based on the auto-reported absence of anosmia to the odorants used in the study. Moreover, knowing that some studies have not found the correlation between self-reported olfactory function and objectively measured olfactory function (Landis et al. 2003) , the anosmia to the studied odorants was also controlled. Thus, all subjects who could not perceive one or several odors during the olfactory tests were excluded of the study (this was the case for 1 subject who had the difficulties to perceive several odors).
The demographic, clinical, and psychometric characteristics of the 3 groups of subjects are presented in Table 1 .
General design
This study was a prospective, longitudinal observational study. Approval from the local ethics committee board (Ethics committee of Tours Ouest-1, France) was obtained, and the study was conducted in accordance with the Good Clinical Practice procedures and the current Declaration of Helsinki for medical research involving human subjects.
The experimental procedure was clearly explained to all participants, and written informed consent was obtained prior to testing. The participants were informed of the option to discontinue testing at any time.
Prior to the initiation of testing, all tasks were explained to the participants, and a brief training session was conducted. First, we assessed the participants with psychometric scales. The subjects were subsequently asked to evaluate the hedonic aspect, familiarity, and emotional impact of the odors and their intensity level. Finally, the evaluation and discrimination of odor intensity were performed. The tasks lasted approximately 1 h and were presented in the same order for all participants. The presentation order of the odorants was balanced across the stimuli and for all subjects, and it was identical for the 3 groups. 13.9 (5.9) 13.7 (6.8) 8.6 (5.9) ###, ttt Pleasure-Displeasure Scale Pleasure, mean score (SD) 7.3 (0.9) 7.3 (0.7) 7.2 (0.5) Displeasure, mean score (SD) 2.8 (0.7) 2.9 (0.6) 3.1 (0.4) ##, tt Neutral, mean score ( For all olfactory tests, the odorant solutions were prepared with distilled water, and the solutions were poured into 60 mL brown glass flasks (10 mL per flask). Each flask was assigned a random 3-digit number. The subjects were not limited with regard to the time allowed for sniffing. However, a 30-s interval between the samples was imposed to prevent olfactory adaptation and saturation.
All olfactory and psychometric evaluations of the patients were conducted by psychiatrists.
Psychometric scales
The State-Trait Anxiety Inventory (STAI; Spielberger 1983) scale was used to evaluate the level of continuous and relational anxiety in the patients at D8 and the healthy controls.
The participants' anhedonic dimension was evaluated with the French translation of the Physical and Social Anhedonia Scales (PAS and SAS; Assouly-Besse et al. 1995), which appreciate the hedonic impact for several social situations, and physical stimuli. These aspects were also evaluated with the Pleasure-Displeasure Scale (PDS; Hardy et al. 1986 ). The PDS measures a subject's affective responses to pleasant, unpleasant, and neutral situations. The 3 clusters of responses were analyzed separately.
Evaluation of the olfactory parameters
Hedonic aspect, familiarity, and emotional impact of odors and their intensity level The participants successively smelled 6 different odorants and were asked to evaluate the hedonic aspect (pleasantness), familiarity, and intensity of the emotion of the perceived odorant stimulus on a 10-cm linear scale labeled as follows at each end: highly unpleasant and highly pleasant; unfamiliar odor and very familiar odor; and weak intensity of emotion and very strong intensity of emotion. The resulting response was expressed in a score that ranged from 0 to 10, which reflects the level of each parameter previously discussed. Before evaluating the intensity of the evoked emotion, each participant selected one of the following emotions: "happiness", "surprise", "disgust", "fear", "sadness", "anger", or "no emotion". The intensity was not evaluated when the last response was chosen. The 6 studied odorants were as follows: 2 odors were pleasant (vanillin at 3 g/l and benzaldehyde [bitter almond] at 0.25 mL/L); 2 odors were neutral (eugenol [clove] at 0.25 mL/L and 1-octen-3-ol [mushroom] at 0.05 mL/L); and 2 odors were unpleasant (hexanoic acid [mold] at 1.6 mL/L and butyric acid [old cheese] at 0.12 mL/L). The odorant compounds were supplied by Fisher Scientific Bioblock (France) and Sigma (Illkirch, France). These compounds are soluble in water, and the selected concentrations were iso-intense and at supra-threshold level.
The few number of studied odors, during this first sensory task is justified with the lot of olfactory tasks asked to the participants and in order to limit the olfactory saturation and tiredness of the subjects.
Evaluation and discrimination of odor intensity
In this olfactory task, the participants evaluated the perceived odor intensity of a series of 14 stimuli presented in a randomized order.
This series was composed of 4 odorants; 2 pleasant (vanillin, VAN and benzaldehyde, BENZ) and 2 unpleasant (butyric acid, BUT and hexanoic acid, HEX). These odorants were presented at 3 different supra-threshold concentration levels (moderate, medium, and high): VAN1 = 0.047 g/L, VAN2 = 0.375 g/L, and VAN3 = 3 g/L; BENZ1 = 0.007 mL/L, BENZ2 = 0.042 mL/L, and BENZ3 = 0.25 mL/L; BUT1 = 0.025 mL/L, BUT2 = 0.2 mL/L, and BUT3 = 1.6 mL/L; and HEX1 = 0.134 mL/L, HEX2 = 0.04 mL/L, and HEX3 = 0.12 mL/L. These concentrations were chosen to be iso-intense and easily differentiated in a preliminary test according to the methodology previously described (Atanasova et al. 2010) . Two stimuli were duplicated (BENZ2 and BUT1) to assess the subjects' repeatability.
A 10-cm linear scale labeled at each end (very low intensity/very high intensity) was used to evaluate the perceived odor intensity of all stimuli.
Statistical analysis
The statistical analyses were performed using non-parametrical tests because the Levene test for the homogeneity of variances revealed an unequal variance for the majority of the variables, and the normal distribution of the data was not validated (Kolmogorov-Smirnov test) .
Regarding the data analysis of the olfactory hedonic and familiarity responses, the odorants were combined into 3 groups, including pleasant (VAN and BENZ), unpleasant (BUT and HEX), and neutral (EUG and OCT), to enhance the statistical reliability. For the same reason, the olfactory intensity evaluation data were regrouped into 2 groups, pleasant (VAN and BENZ) and unpleasant (BUT and HEX).
A Mann-Whitney unpaired test was used to compare the patients at D8 versus the controls and the patients at D67 versus the controls, and a Wilcoxon signed paired test was used to compare the patients at D8 versus the patients at D67. These 2 tests were performed with a Bonferroni correction (α* = α/k, where α = 0.05 and k is the number of the comparisons performed; i.e., α* = 0.025). They were used to compare the scores of the psychometric evaluations (STAI, PAS, SAS, and PDS) and olfactory measures (odor hedonic response, odor familiarity level, odor intensity, and emotional intensity evoked through perceived odor).
The Wilcoxon signed paired test was also used to study the testretest reliability of the intensity responses of each group of subjects for 2 odorants (BENZ2 and BUT1).
The Friedman test was performed to study the discrimination of the odor intensity (3 different concentration levels) of the 4 odorants (VAN, BENZ, BUT and HEX) for each group of subjects. The post hoc Nemenyi procedure permitted 2-by-2 comparisons of the intensity score of the 3 different concentration levels. These 2 statistical tests were Bonferroni corrected (α = 0.0167).
Regarding the type of emotion selected when the odor was perceived, for each emotion and population, the sum of citations was calculated for all 6 odorants. The Chi-squared test was used to test for differences between groups in the proportions of subjects who chose the different emotions. When this test identified a significant difference between the groups for their responses, a Chi-squared test for each type of emotion was performed to identify the type of difference between the 3 groups. If this latter test was significant, multiple pairwise comparisons that used the Marascuilo procedure were performed. The Chi-squared test and the Marascuilo procedure were Bonferroni corrected (α = 0.0167).
The Spearman correlation coefficient was used to study the relationship between the clinical subjects' state and their olfactory performances. The Spearman coefficient was calculated for the 2 patient groups and the significant results obtained in the olfactory tests and scales. This final statistical analysis was performed at α = 0.05.
To process the results, we used the statistical software XLSTATPro version 5.2.
Results
Psychometric assessments
Regarding the anxiety inventory scale, a significant difference was identified between the patients at D8 and the controls for both state (U = 1351, P < 0.0001) and trait (U = 1461, P < 0.0001) mean scores (Table 1) .
At D8 and D67, the patients exhibited significantly higher social (D8: U = 1332, P < 0.0001; D67: U1265, P < 0.0001) and physical (D8: U = 1196, P = 0.001; D67: U = 1153, P = 0.004) anhedonia scores compared with the healthy controls. No significant difference was identified between the patient groups for social (V = 365, P = 0.84) or physical (V = 431, P = 0.56) anhedonia (Table 1) .
Regarding the pleasure-displeasure scale results, a significant difference was identified between the 2 groups of patients and the controls for displeasure (patients at D8 vs. controls: U = 503, P = 0.002; patients at D67 vs. controls: U = 503, P = 0.002) and neutral (patients at D8 vs. controls: U = 1083, P = 0.024; patients at D67 vs. controls: U = 1098, P = 0.017) situations. However, no significant difference between the 3 groups was identified for the pleasure situations (patients at D8 vs. D67: V = 486, P = 0.47; patients at D8 vs. controls: U = 998, P = 0.14; patients at D67 vs. controls: U = 971, P = 0.23) or for patient groups concerning displeasure situations (U = 339, P = 0.34) and neutral (U = 377, P = 0.70) situations (Table 1) .
Evaluation of the olfactory parameters
Hedonic aspect
The results demonstrated a significant difference between the 2 groups of patients and between the patients at D8 and the controls for pleasant (patients at D8 vs. D67: V = 171, P = 0.002; patients at D8 vs. controls: U = 589, P = 0.02) and neutral (patients at D8 vs. D67: V = 189, P = 0.005; patients at D8 vs. controls: U = 479, P = 0.001) odorants.
Regarding the unpleasant odorants, no significant differences were identified between the patients at D8 and D67 (V = 388, P = 0.59) or between the 2 patient groups and the healthy subjects (patients at D8 vs. controls, U = 894, P = 0.62; patients at D67 vs. controls, U = 962, P = 0.26).
No significant differences were identified between the patients at D67 and the controls for pleasant (U = 831, P = 0.94) or neutral (U = 738, P = 0.34) stimuli (Table 2) .
Familiarity
The results indicated that the patients at D8 compared with the patients at D67 and the controls evaluated the pleasant (patients at D8 vs. D67: V = 243, P = 0.025; patients at D8 vs. controls: U = 536, P = 0.005), unpleasant (patients at D8 vs. D67: V=123, p<0.0001; patients at D8 vs. controls: U = 592, P = 0.02), and neutral (patients at D8 vs. D67: V = 188, P = 0.002; patients at D8 vs. controls: U = 511, P = 0.002) stimuli as significantly less familiar. No significant differences were identified between the patients at D67 and the controls for pleasant (U = 798, P = 0.70), unpleasant (U = 945, P = 0.33), or neutral (U = 711, P = 0.23) stimuli (Table 2) .
Emotional impact of odors and their intensity
The results of the 3 types of responses ("anger", "sadness", and "no emotion") were not statistically analyzed because of the limited number of citations: less than 5 ("anger": 2.0% for patients at D8, 2.4% for patients at D67 and 0.8% for controls; "sadness": 2.9% for patients at D8, 2.9% for patients at D67 and 1.2% for controls; "no emotion": 0.8% for patients at D8, 0.4% for patients at D67 and 13% for controls). The choice of "no emotion" was the third most common judgment in healthy controls, which was not the case for both patients groups. Therefore, this point is discussed in the discussion section.
Regarding the emotional impact of odors, the Chi-squared test demonstrated a significant difference between the 3 groups concerning the number of responses of the different types of emotion (χ 2 = 18.9, P = 0.004).
When the 3 groups were compared for each emotion, the results demonstrated a significant difference only for "surprise" (χ 2 = 20.7, P < 0.0001). "Surprise" was cited significantly more frequently by patients in both evaluations compared with controls. No significant difference was identified between the 3 groups with regard to "disgust" (χ 2 = 0.4, P = 0.8), "happiness" (χ 2 = 3.8, P = 0.15), or "fear" (χ 2 = 0.7, P = 0.7) (Figure 1 ). Regarding the intensity of odor emotions, the results of the "anger" emotion, were not statistically analyzed because of the low number of values: only 2 values for controls.
Significant differences between the patients at D8 and the controls were identified for "surprise" (U = 960, P < 0.0001), "happiness" (U = 3511, P = 0.008), and "sadness" (U = 48, P = 0.003). A significant difference concerning the intensity of the same 3 emotions was also observed between the patients at D67 and the controls (for "surprise": U = 1160, P < 0.0001; for "happiness": U = 3598, P = 0.016; and for "sadness": U = 47, P = 0.004). The results revealed no significant differences between the patient groups for "surprise" (V = 882, P = 0.29), "happiness" (V = 2327, P = 0.7), or "sadness" (V = 15, P = 0.9). Additionally, no significant differences between the 3 groups were observed for the intensity evaluation of "disgust" (patients at D8 vs. D67: V = 1412, P = 0.05; patients at D8 vs. controls: U = 3953, P = 0.61; and patients at D67 vs. controls: U = 3424, P = 0.28) or "fear" (patients at D8 vs. D67: V = 9, P = 0.04; patients at D8 vs. controls: U = 48, P = 0.43; and patients at D67 vs. controls: U = 88, P = 0.08) (Figure 2 ).
Evaluation and discrimination of odor intensity
The results demonstrated that the patients at D8 perceived the unpleasant odors as significantly more intense compared with the patients at D67 (V = 666, P = 0.002) and the controls (U = 1084, P = 0.024). No significant difference in perceived intensity between the patients at D67 and the healthy subjects was identified (U = 751, Table 2 . Comparison of the mean scores (SD) of hedonic aspect and familiarity of odorants (pleasant, neutral, and unpleasant) among patients at day 8 (D8), patients at day 67 (D67), and control subjects P = 0.41) for unpleasant odors. There was no significant difference in perceived intensity between the 3 groups concerning the pleasant odorants (patients at D8 vs. D67: V = 594, P = 0.03; patients at D8 vs. controls: U = 1025, P = 0.09; and patients at D67 vs. controls: U = 794, P = 0.67) (Figure 3) .
Regarding the discrimination of odor intensity, we determined that the 3 groups were able to evaluate at least one concentration as significantly less or more intense than the 2 other concentrations for all studied odorants (patients at D8: VAN, Q = 38.7, P < 0.0001; BENZ, Q = 19.3, P < 0.0001; BUT, Q = 42.2, P < 0.0001; HEX, Q = 16.5, P < 0.0001; patients at D67: VAN, Q = 58.3, P < 0.0001; BENZ, Q = 48.2, P < 0.0001; BUT, Q = 54.9, P < 0.0001; HEX, Q = 53.7, P < 0.0001; controls: VAN, Q = 28.0, P < 0.0001; BENZ, Q = 44.7, p<0.0001; BUT, Q = 59.5, P < 0.0001; HEX, Q = 43.6, P < 0.0001). However, only the healthy subjects were able to correctly discriminate the 3 different concentration levels of the 4 odorants ( Table 3) . The patients at D8 discriminated the 3 different concentrations of only 1 odorant (VAN). After 67 days of abstinence, they discriminated the 3 different concentrations for 2 (VAN and HEX) of the 4 odorants ( Table 3) .
Repeatability of intensity evaluation
No significant difference was observed for the 2 repetitions of the intensity evaluation of both odorants (BENZ2 and BUT1) for the patients at D8 (BENZ2: V = 384, P = 0.55; BUT1: V = 335, P = 0.82), the patients at D67 (BENZ2: V = 436, P = 0.11; BUT1: V = 310, P = 0.82), or the healthy controls (BENZ2: V = 408, P = 0.78; BUT1: V = 308, P = 0.12).
Correlations
For the patients at D8, the duration of alcohol consumption was positively and significantly correlated with the social anhedonia (r = 0.32, P = 0.043) and anxiety state/trait scores (state: r = 0.33, P = 0.037; trait: r = 0.42, P = 0.006). The neutral score of the pleasure-displeasure scale was positively correlated with the intensity of the negative stimuli (r = 0.35, P = 0.025) and negatively correlated with the familiarity level of the pleasant odorants (r = −0.36, P = 0.02).
Three significant correlations were also identified for the patients at D67. The duration of alcohol consumption was positively and significantly correlated with the social anhedonia (r = 0.33, P = 0.036) and MADRS (r = 0.53, P = 0.001) scores. The social anhedonia scores were also negatively correlated with the familiarity level of the unpleasant odorants (r = −0.36, P = 0.022).
Discussion
This pilot study aimed to propose a potential state and trait olfactory alterations associated with alcohol dependence via an evaluation of olfactory performance during the early stage of abstinence and after 9 weeks of treatment and controlled abstinence. The same 41 subjects participated in the 2 stages of olfactory and psychometric evaluations, thus being their own witnesses. Their results were compared to those of 41 healthy controls. Six controls were also retested after 2 months in order to study the repeatability of the results. The repeatability of all olfactory parameters has been validated.
The main findings of this work are the identification of significant differences in the olfactory functions of alcohol-dependent subjects compared with controls. Some differences tend to disappear or normalize after 9 weeks of controlled abstinence, whereas other differences persist. These differences are accompanied by psychometric changes, and the duration of alcohol consumption appears to be related to the patients' clinical characteristics.
First, the results of some olfactory parameters shed light on several olfactory alterations that could constitute probable trait markers of alcohol dependence. These findings are particularly evident in the study of the emotion evoked by odor and the evaluation of its intensity level.
Regarding the evoked emotions in the perception of odorants, a difference between patients and controls has been observed only for "surprise", which can be positively or negatively affected (Westbrook and Oliver 1991) . This emotion was cited significantly more frequently by the patients at D8 and D67 compared with the healthy individuals. It was also evaluated, just like "happiness", as significantly less intense by patients. This result suggests that for patients, "surprise" was perceived as a positive emotion. However, this does not correspond with our initial hypothesis in which we expected that the patients would choose the positive emotion less frequently than the controls. Another surprising result concern the choice of "no emotion": 13% for controls and less than 1% for both patient groups. It seems that patients tended to persevere in their response by choosing necessarily an emotion to each odor, even if that emotion was not necessarily felt during odor perception. Theses unexpected results could be explained by the alexithymia that is frequently described in alcohol-dependent individuals (for review, see Thorberg et al. 2009 ), which may persist after abstinence (Bochand and Nandrino 2010) . Moreover, our results demonstrated that one negative emotion, "sadness", was evaluated as significantly more intense by the patients (at D8 and D67) compared with the controls. This finding may be due, in part, to the higher scores on depressed symptoms (without necessarily involving a major depressive episode) in the patients at D8 and D67, which may induce negative alliesthesia related to the selective processing of negative information (Beck 1976) , even if we did not find any positive correlation between MADRS score and hedonic response. The finding of the pleasure-displeasure scale, which demonstrated a greater tendency to over-note displeasure items among patients at D8 and D67 compared with the healthy subjects, strengthens this hypothesis. These observations can be considered in the context of previous results on alcohol dependence, which were obtained in another sensory field (the study of emotional facial expression recognition) and demonstrated a preferential selection of more negative emotional labels, especially "sadness" (Foisy et al. 2007) .
Taken together, these results suggest negative potentiation and positive attenuation (olfactory anhedonia) at the olfactory emotional level. These results may also be explained by the clinical anhedonia (social and physical) observed in our patients, which persisted after 9 weeks of abstinence. This component of the depressive dimension (anhedonia is 1 of the 2 cardinal symptoms of depression, DMS-IV) is consistent with the study conducted by Volkow et al. (2002) , which demonstrated lower levels of striatal dopamine D2 receptors in alcohol-dependent patients compared with controls, with no significant improvement after abstinence. These authors raised the possibility of a predisposing factor. Other authors have suggested that anhedonia is one of the symptoms of abstinence and is an important factor in relapse (Hatzigiakoumis et al. 2011) .
Second, the results of the hedonic perception of odors and other olfactory parameters that involve a more cognitive task (i.e., odor's familiarity and intensity evaluation and discrimination) demonstrate Odor intensity mean scores (SD) of vanillin (VAN), benzaldehyde (BENZ), butyric acid (BUT), and hexanoic acid (HEX) evaluated in patients at day 8 (D8), in patients at day 67 (D67), and in control subjects (CS). The results must be read in columns: for each odorant and for each group of subjects, mean values with the same letter are not significantly different at α = 1.67% using the Nemenyi procedure (the significance level is Bonferroni corrected). Concentration levels: C1, C2, and C3. olfactory biases in alcohol-dependent patients that are restored after 67 days of treatment and controlled abstinence.
Concerning the hedonic evaluation of odors, our results demonstrate an olfactory bias in alcohol-dependent patients that is restored after 9 weeks of abstinence. This result supports our hypothesis that pleasant stimuli are perceived as less pleasant by alcohol-dependent patients compared with healthy controls (olfactory anhedonia). In addition, the same decreased hedonic score for patients at D8 was observed for neutral odorants (i.e., clove and mushroom), which correspond to non-emotional odors, suggesting a more generalized hedonic olfactory bias. This last unexpected result may be explained by the patients' alexithymia, which was previously suggested in this manuscript with regard to the emotional perception of odors. In contrast with our results, a previous study identified the preservation of pleasantness evaluations in alcohol-dependent subjects compared with controls using mainly pleasant odorants (score calculated as a mean of all odorants, i.e., irrespective of the odors' hedonic valence) (Rupp et al. 2004) . The difference in findings of prior research may be related to the fact, that our sample at D8 is a "highly medicated" patients sample and some patients were perhaps in "withdrawal state" (in the present study 5 patients carried out the olfactory tests after only 3-5 days of abstinence) compared to no/less medicated samples with mean abstinence durations of about 1 month in prior study.
Regarding the familiarity evaluation of odors, our results reveal a generalized olfactory deficiency in alcohol-dependent patients that disappeared after 9 weeks of abstinence. Decreased familiarity scores were observed in the patients at D8 compared with healthy subjects for all odorants regardless of their hedonic valence (pleasant, unpleasant, or neutral) . It has been suggested that the process of familiarity ratings is related to a subject's general knowledge or experience with a specific odorant and that this specific olfactory knowledge is strongly and positively related to episodic memory performance (Larsson and Bäckman 1998) . Episodic memory deficits have been observed in alcohol-dependent subjects (for review, see Bernardin et al. 2014) , which could explain, in part, the generalized olfactory deficit related to the familiarity rating of our patients. Our data are consistent with a previous study that identified impairment in familiarity judgment in alcohol-dependent subjects (Rupp et al. 2004) . The authors showed that this impairment was independent of age and gender and was not attributed to psychotropic medication or smoking. In the present study, we also demonstrated that this impairment appears to be dependent on patients' psychometric characteristics.
Our results indicate that olfactory impairments in alcohol dependence also include the processing of odor intensity, which depends on the odor's hedonic valence. Increased odor intensity perception in patients at D8 compared with the controls was observed only for unpleasant odorants, which suggests that negative olfactory alliesthesia was also observed in our patients for the intensity perception of a negative emotion (sadness). Furthermore, no difference in the odor intensity rating for pleasant odorants was observed between the patients and healthy individuals. Without taking into account, the potential influence of odors' hedonic valence on their perceived intensity (score calculated as a mean of all odorants), Rupp et al. (2004) did not identify an alteration in the intensity rating in alcohol dependence. As it is already suggested for the results concerning hedonic evaluation, we can explain this discrepancy with the high medication of our patients at D8 compared to the patients participating in the previous study.
Our results demonstrated a recovery of both familiarity and intensity odor evaluations after 9 weeks of controlled abstinence. Because these 2 olfactory parameters imply a cognitive task, we can explain their reestablishment by the rapid recovery from general cognitive deficits observed in abstinent alcoholics (Mann et al. 1999) . Moreover, it is important to note that, a comparison of findings of all olfactory parameters in alcohol-dependent patients with a longer duration of abstinence (at D67) (and fewer patients under benzodiazepine treatment) with prior research is limited due to the lack of healthy controls tested twice (only 6 controls were retested in this study).
Furthermore, the alcohol-dependent patients at D8 failed to correctly discriminate the 3 different intensity levels for 3 (1 pleasant and 2 unpleasant odorants) of the 4 studied odorants, regardless of their hedonic valance. However, this olfactory deficit tends to improve after the cessation of alcohol consumption (day 67). The reliability of these results was confirmed in the present study. It has been suggested that the odor discrimination task is related to olfactory working memory (Zucco et al. 2014 ). Thus, a deficit in working memory (Ambrose et al. 2001) , which is related to a prefrontal dysfunction in alcohol-dependent patients (Rupp et al. 2006) , may explain this olfactory bias. We could also hypothesize that the failing to correctly discriminate the 3 levels of odors' intensity could be due to a deficit in olfactory threshold. Indeed, several studies demonstrated significantly reduced olfactory sensitivity (higher threshold), for alcohol-dependent patients compared with controls (Rupp et al. 2003) . Hence, in this study, it would have been interesting to perform a screening test of olfactory function in order to confirm this hypothesis.
In summary, this pilot study provides new evidence regarding olfactory impairments associated with alcohol dependence by highlighting a probable state and trait olfactory markers of this disease. Our results reveal the presence of "olfactory anhedonia", "olfactory negative alliesthesia", and "olfactory alexithymia", which were expressed, respectively, by a decreased intensity of positive emotion ("happiness"), an increased intensity of negative emotion ("sadness"), and an increased citation of "surprise" as possible trait markers for alcohol dependence. Our results also demonstrate the presence of (i) "olfactory anhedonia" expressed by decreased hedonic scores for pleasant and neutral odorants, (ii) "olfactory negative alliesthesia" at a quantitative level (increased intensity score for unpleasant odorants and a failure to discriminate odor intensities), and (iii) a decreased odor familiarity judgment as probable state markers for alcohol dependence.
Although data regarding cortical olfactory processing remain nonhomogeneous, neuroimaging studies in healthy subjects indicate that various olfactory tasks (i.e., discrimination) and odor characteristics (pleasantness, intensity, and familiarity) that require emotional and/ or cognitive involvement may have dissociated neural substrate representations in the nervous system (Zald and Pardo 1997; Zatorre et al. 2000; Royet et al. 2001; Savic 2001; Anderson et al. 2003 ). Our results demonstrate specific olfactory deficits according to the clinical patient's state: the presence of both emotional and cognitive olfactory impairments in the early stage of abstinence and the persistence of only emotional olfactory impairments after 9 weeks of controlled abstinence, which suggests that different brain regions may be associated with these olfactory deficits during the stages of abstinence. Complementary studies in alcohol-dependent subjects, including neuroimaging investigations, would provide insight into the underlying neural correlates of the olfactory dysfunctions observed in various stages of abstinence. Another explication of the observed difference in olfactory functioning between patients at early and late stage of abstinence could be the use of benzodiazepines for the majority of patients at D8. Several studies (both in animals and humans) have suggested that these drugs may alter olfaction, as well as several neuropsychological performances (Sokolic et al. 2007; Kroon et al. 2009; Scott et al. 2016 ). This aspect must be check on in further studies aimed to compare the olfactory and neuropsychological performances in the early stage of abstinence in 2 patients groups: with and without benzodiazepines medication. Besides, it is well known that benzodiazepines may affect vigilance and attention. In this study, the administered doses of diazepam have been low (mean = 25.2 mg/day; SD = 21.21). Nevertheless, complementary investigations are needed in order to control these parameters to ensure that differences between the 2 patient groups could not be due to an effect of attention/vigilance. Some limitations of this study merit discussion. First, confirmation of the specificity and sensitivity of the olfactory tests in a larger sample, including several age ranges, is needed to create standardized tools. Moreover, in the present study only 6 odors with different hedonic valence ("2 pleasant", "2 unpleasant", and 2 "neutral" odors) were used. In order to enhance the reliability of the results, further research using several olfactory stimuli with contrasting hedonic valence is needed to confirm our results. Second, longitudinal studies are required to examine emotional, cognitive, and olfactory performances in alcohol-dependant individuals following the duration of abstinence to confirm the hypothetical olfactory markers for alcohol dependence. Another limitation of this work concerns the study protocol; more precisely all healthy controls should have been tested twice, in order to compare their results with those of patients with a longer duration of abstinence (D67) and in order to validate the results concerning the presence of the olfactory state and trait markers of alcohol dependence. Third, we did not exactly match the educational level of the patients and the control individuals who participated in the study. Although several studies have revealed an influence of educational level on the odor identification task (Boesveldt et al. 2011; Orhan et al. 2012) , no data have demonstrated the effect of this parameter on other high-level olfactory functions. This point must be controlled in future studies. Another limitation concerns medication. Several patients included in this research exhibited a long history of alcohol dependence and/or were simultaneously treated with several drugs for chronic diseases (see section "Materials and methods": participants). Therefore, the potential effects of chronic medication and the synergy of multiple drug use cannot be excluded.
In the future, it would be interesting to develop research on the interaction between olfaction and alcoholism with an examination of a potential causal link by focusing on the timing of the onset of disorders. It would also be useful to specify the neuropsychological alterations (executive functions, alexithymia, and anhedonia) and clarify their roles in the pathophysiological mechanisms that unite both olfactory and alcohol-dependence disorders. On a clinical level, several therapeutic approaches should be explored. For example, to date, the influence of even partial improvement of olfactory alterations in the dependency syndrome has not been reported. Finally, as suggested in previously research works (Rupp et al. 2004) , another point that deserves attention is the determination of specific olfactory markers in the different psychiatric diseases with special care for the common comorbidity of alcohol-use disorders (e.g. depression, anorexia, post-traumatic stress disorder). The identification of olfactory deficits that result from a psychiatric disorder, on the one hand, and the comorbidity of alcohol, on the other hand, could enrich the theoretical and clinical understanding of these conditions and could facilitate better care for patients.
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